Nov 21, 2019
Breakthrough Gene Therapy Clinical Trial is the World's First That Aims to Reverse 20 Years of Aging in Humans
Nov 13, 2019
AMRA Medical Abstract Selected for AASLD's "Best of The Liver Meeting" Showcase
Nov 07, 2019
Arkuda Therapeutics Closes $44M Series A Financing to Advance Novel Medicines Targeting Progranulin and Lysosomal Biology to Treat Neurodegenerative Diseases
Nov 06, 2019
Artios Pharma, MD Anderson and ShangPharma Announce In-Licensing Agreement for DNA Damage Response Inhibitor
Oct 30, 2019
Global Orthobiologic Musculoskeletal Soft Tissue Replacement and Regeneration Analysis Report 2019
Oct 23, 2019
New Study Reveals Method Linking AMRA Medical's Muscle Biomarkers and Function
Oct 22, 2019
'Practical Strategies for Preventing Blindness Caused by AMD' Offers Clear Framework on How to Manage AMD in Optometric Practice
Oct 07, 2019
Stealth BioTherapeutics Presents Data on SBT-272 in Neurodegeneration
Oct 07, 2019
Kodiak Sciences Announces Upcoming Presentation of Durability Data from Clinical Development Program of KSI-301 in Wet AMD, DME, and RVO at American Academy of Ophthalmology 2019 Annual Meeting
Oct 01, 2019
LumiThera Enrolls First Patient in the U.S. Multi-Center, LIGHTSITE III Clinical Study to Treat Dry Age-Related Macular Degeneration
Sep 27, 2019
Global Emerging Therapeutics Markets for Neurodegenerative Diseases, 2019: Focus on Novel Targeted Therapeutic Strategies Technologies for Alzheimer's and Parkinson's Diseases
Sep 23, 2019
4D pharma plc: Publication of Data on Neurodegenerative Disease Programmes
Sep 18, 2019
DELPhi- A New Groundbreaking Technology for Brain Health Imaging
Sep 12, 2019
Growth Opportunities in the Neurodegenerative Disorder Therapeutics Market - Global Forecast to 2024
Sep 05, 2019
Emerging Therapeutics for Neurodegenerative Diseases, Part I: Novel Targeted Therapeutic Strategies Technologies for Alzheimer's and Parkinson's Diseases
Aug 14, 2019
Bach Pharma Inc, Developing New Drug, GVT® to Treat Veterans Suffering from Gulf War Illness, and Millions of People Suffering from Neurodegenerative Diseases
Aug 08, 2019
Eiger BioPharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update
Jul 24, 2019
The huge unmet medical need of dry AMD is expected to drive the market at a CAGR of over 8% during the forecast period
Jun 10, 2019
Eiger Appoints Industry Veteran and Regulatory Affairs Expert Mark Mannebach, PhD, RPh as Vice President of Global Regulatory Affairs
Jun 05, 2019
Large Gaps in Life Expectancy in Major U.S. Cities Linked to Racial/Ethnic Segregation by Neighborhood